Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Anne Françoise Schlit"'
Autor:
Annie Delaunois, François‐Xavier Mathy, Miranda Cornet, Vitalina Gryshkova, Chloé Korlowski, François Bonfitto, Juliane Koch, Anne‐Françoise Schlit, Simon Hebeisen, Elisa Passini, Blanca Rodriguez, Jean‐Pierre Valentin
Publikováno v:
Pharmacology Research & Perspectives, Vol 11, Iss 1, Pp n/a-n/a (2023)
Abstract Levetiracetam (LEV), a well‐established anti‐seizure medication (ASM), was launched before the original ICH S7B nonclinical guidance assessing QT prolongation potential and the introduction of the Comprehensive In Vitro Proarrhythmia Ass
Externí odkaz:
https://doaj.org/article/8e3d0b97aa3843f1ab02c7d3ae9a2afc
Autor:
Alex Iranzo, Pedro Serralheiro, Jan-Christof Schuller, Anne-Françoise Schlit, Jürgen W. G. Bentz
Publikováno v:
Drugs - Real World Outcomes, Vol 7, Iss 4, Pp 307-315 (2020)
Abstract Background Sodium oxybate (Xyrem®), approved by the European Medicines Agency (EMA) for narcolepsy with cataplexy, is only available through risk mitigation programs due to potential adverse effects including respiratory and central nervous
Externí odkaz:
https://doaj.org/article/e6e78d7b77f24b50825effc33b22737a
Autor:
Annie Delaunois, François‐Xavier Mathy, Miranda Cornet, Vitalina Gryshkova, Chloé Korlowski, François Bonfitto, Juliane Koch, Anne‐Françoise Schlit, Simon Hebeisen, Elisa Passini, Blanca Rodriguez, Jean‐Pierre Valentin
Publikováno v:
Pharmacology Research & Perspectives. 11
Publikováno v:
Drugs-Real World Outcomes
Drugs-Real World Outcomes, Vol 7, Iss 4, Pp 307-315 (2020)
Drugs-Real World Outcomes, Vol 7, Iss 4, Pp 307-315 (2020)
Background Sodium oxybate (Xyrem®), approved by the European Medicines Agency (EMA) for narcolepsy with cataplexy, is only available through risk mitigation programs due to potential adverse effects including respiratory and central nervous system d
Publikováno v:
Journal of Obstetrics and Gynaecology. 38:940-945
Managing symptoms of allergic rhinitis (AR) and urticaria in pregnant women is important to reduce complications and negative outcomes. The objective of this study was to provide information on the pregnancy outcomes of women exposed to the antihista
Autor:
J. W. G. Bentz, Geert Mayer, Juan Ortega-Albás, Didier Wuiame, Giuseppe Plazzi, Anne Françoise Schlit, Timothy G. Quinnell, Alex Iranzo, Hanna Pesch, Pedro Serralheiro
Publikováno v:
Sleep
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-FISABIO. Repositorio Institucional de Producción Científica
instname
Study Objectives: To evaluate adherence to sodium oxybate prescribing information for indication and dosage, patients' compliance with instructions for use, safety/tolerability in routine clinical practice, and abuse potential. Methods: A postauthori
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d17b4a6d25807c7bbeef9bab4e78644
http://hdl.handle.net/11585/659910
http://hdl.handle.net/11585/659910
Autor:
Eva Andermann, Steven J. Frucht, Adriana Magaudda, Reetta Kälviäinen, Danielle Gerard, Philipp von Rosenstiel, Frederick Andermann, Pierre Genton, Christine de la Loge, Anne-Françoise Schlit
Publikováno v:
Epilepsia. 57(2)
Summary Objective To evaluate efficacy, tolerability, and safety of adjunctive brivaracetam (BRV) in patients with Unverricht-Lundborg disease (EPM1). Methods Two prospective, multicenter, double-blind, phase III trials (N01187/NCT00357669; N01236/NC
Autor:
Jean-Pierre Valentin, Christopher Peters, Annie Delaunois, Rossen Boev, Victor S. Sloan, Aurore Colomar, Anne-Françoise Schlit, J. W. G. Bentz, Luca Cariolato, Branderley Claudio
Publikováno v:
Pharmacology Research & Perspectives
Several noncardiac drugs have been linked to cardiac safety concerns, highlighting the importance of post‐marketing surveillance and continued evaluation of the benefit‐risk of long‐established drugs. Here, we examine the risk of QT prolongatio
Publikováno v:
Thrombosis Research. 84:203-206
Pregnancy induces several haemostatic perturbations. Some authors described possible acquired activated protein C resistance (APCR) during normal pregnancy. We wanted to test this possibility and to evaluate if this acquired APCR might contribute to
Autor:
Aurore Colomar, Christopher Peters, Annie Delaunois, Jean-Pierre Valentin, Anne-Françoise Schlit
Publikováno v:
Journal of Pharmacological and Toxicological Methods. 81:354